ADAM17 and neoplasm: In recent studies, miR-145 has been proven to inhibit the proliferation, invasion, and metastasis of tumor cells; increase the sensitivity of tumor cells to chemotherapy; and regulate the occurrence and development of tumors by targeting ADAM17 in several malignant tumors [23,37,38,39,40].